Literature DB >> 2837468

Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.

H Maegawa1, D A McClain, G Freidenberg, J M Olefsky, M Napier, T Lipari, T J Dull, J Lee, A Ullrich.   

Abstract

We have previously shown that a mutant human insulin receptor with a COOH-terminal 43-amino acid deletion (HIR delta CT), when expressed in Rat 1 fibroblasts, binds insulin normally, autophosphorylates, and undergoes endocytosis after insulin binding in a manner comparable to the normal human insulin receptor (HIRc). In this paper we have examined the biologic activity of the truncated and normal insulin receptors. In vitro, the HIR delta CT receptors caused a 1.8-fold greater phosphorylation of a Glu4/Tyr1 polypeptide than did the HIRc receptors, but the two receptor types were nearly equivalent in their ability to phosphorylate a src-derived peptide. Furthermore, insulin preactivation of HIRc and HIR delta CT receptors in intact cells led to equivalent stimulation of tyrosine kinase activity as subsequently determined for histone in vitro. Expression of HIRc receptors in cells led to enhanced sensitivity to insulin of 2-deoxy-D-glucose uptake and glycogen synthase activation. This increased sensitivity was proportional to receptor number at low (Ro = 6400) but not at high (Ro = 1.25 X 10(6] levels of receptor expression. However, expression of HIR delta CT receptors (Ro = 2.5 X 10(5] led to little, if any, increase in insulin sensitivity of either 2-deoxy-D-glucose uptake or glycogen synthase activation. Furthermore, compared with HIRc cells, HIR delta CT cells respond poorly to an agonistic monoclonal antibody specific for the human insulin receptor. In conclusion, the HIR delta CT receptor retains intact protein kinase activity in vitro. Despite this, however, the receptor displays low activity in mediating the metabolic effects of insulin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837468

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance.

Authors:  H U Häring
Journal:  Diabetologia       Date:  1991-12       Impact factor: 10.122

2.  Functional heterogeneity of proto-oncogene tyrosine kinases: the C terminus of the human epidermal growth factor receptor facilitates cell proliferation.

Authors:  T J Velu; W C Vass; D R Lowy; L Beguinot
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

3.  The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.

Authors:  P Soni; M Lakkis; M N Poy; M A Fernström; S M Najjar
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Dephosphorylation of insulin-receptor autophosphorylation sites by particulate and soluble phosphotyrosyl-protein phosphatases.

Authors:  M J King; G J Sale
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

Review 5.  Autophosphorylation: a salient feature of protein kinases.

Authors:  J A Smith; S H Francis; J D Corbin
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

6.  Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling.

Authors:  Francesca Fiory; Anna Teresa Alberobello; Claudia Miele; Francesco Oriente; Iolanda Esposito; Vincenzo Corbo; Menotti Ruvo; Barbara Tizzano; Thomas E Rasmussen; Steen Gammeltoft; Pietro Formisano; Francesco Beguinot
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

7.  The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity.

Authors:  P P Di Fiore; O Segatto; F Lonardo; F Fazioli; J H Pierce; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  Changes in insulin-receptor tyrosine, serine and threonine phosphorylation as a result of substitution of tyrosine-1162 with phenylalanine.

Authors:  J M Tavaré; M Dickens
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

9.  Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions.

Authors:  D Liu; C S Zong; L H Wang
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.

Authors:  T S Pillay; S Xiao; J M Olefsky
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.